Search
for
Sort by
Research 151–180 of 1000+
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
- JAK Inhibitors for Treatment of Alopecia Areata
- Treatment of alopecia universalis with topical Janus kinase inhibitors – a double blind, placebo, and active controlled pilot study
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- Comparative efficacy and safety of systemic steroids, oral JAK inhibitors and Contact Immunotherapy in the Treatment of severe alopecia areata: a systematic review and network meta-analysis
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
- Short-term malignancy risk of JAK inhibitors in severe alopecia areata: a multicenter cohort study
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- Short-term Efficacy of Tofacitinib, a JAK Inhibitor, in IFIH1-related Aicardi-Goutières Syndrome
- Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis
- Screening for latent infectious disease in patients with alopecia areata before initiating JAK inhibitors therapy: a single-center real-world retrospective study
- The development of oral hairy leukoplakia during JAK inhibitor baricitinib therapy
- Medicaid coverage of Janus kinase inhibitors for alopecia areata treatment
- Hair growth–promoting effects of Enz_MoriL on human dermal papilla cells through modulation of the Wnt/β-Catenin and JAK-STAT signaling pathways
- Biologic Therapies and Small-Molecule Inhibitors for Dissecting Cellulitis of the Scalp: A Systematic Review
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Simultaneous improvement of alopecia universalis and atopic dermatitis in a patient treated with a JAK inhibitor
- Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- Tumor necrosis factor inhibitors and janus kinase inhibitors in the treatment of cicatricial alopecia: A systematic review
- Efficacy of Janus kinase inhibitors in adult patients with alopecia areata
- Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata
- JAK Inhibitors in African American Patients With Alopecia Areata: A Case Series
- The evaluation of JAK inhibitors on effect and safety in alopecia areata: a systematic review and meta-analysis of 2018 patients
- A Review on the Use and Effectiveness of JAK Inhibitor in the Management of Lichen Planopilaris
- Treatment Response to JAK Inhibitors in Long-standing Alopecia Areata (≥8 Years): A Real-world Observational Study